Thorne HealthTech (NASDAQ:THRN) Given New $7.00 Price Target at Canaccord Genuity Group

Thorne HealthTech (NASDAQ:THRN – Free Report) had its target price lifted by Canaccord Genuity Group from $6.00 to $7.00 in a research report sent to investors on Friday, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Separately, TheStreet raised Thorne HealthTech from a d+ rating to a c- rating in […]

Related Keywords

United States ,American ,Thorne Healthtech ,Thorne Healthtech Company Profile ,Thorne Healthtech Inc ,Jpmorgan Chase Co ,Barclays Plc ,Canaccord Genuity Group ,Virtu Financial ,American International Group Inc ,Allspring Global Investments Holdings ,Free Report ,Genuity Group ,Healthtech Stock Down ,International Group ,Global Investments Holdings ,Get Free Report ,Thorne Healthtech Daily ,Nasdaq Thrn ,Thrn ,Medical ,Boost Price Target ,Canaccord Genuity Group Inc ,